Video

VIDEO: Drug cocktail stops uterine AVM bleeding


 

AT THE AAGL GLOBAL CONFERENCE

References

VANCOUVER, B.C. – Bleeding from uterine arteriovenous malformations was stopped with a combination of tranexamic acid, gonadotropin-releasing hormone agonist, and an aromatase inhibitor in a small case series in Canada.

The cocktail appears to be a safe alternative to uterine artery embolization and hysterectomy, which allows women to remain fertile, said Dr. Angelos Vilos, an ob.gyn. at Western University in London, Ontario, and the study’ lead investigator.

Dr. Vilos and his team used uterine tamponade to control bleeding, then gave the women oral tranexamic acid for 5 days. Patients also received a GnRH agonist – usually one injection of leuprolide – with oral letrozole for 5 days after the injection. In all cases, the arteriovenous malformations resolved within 3 months.

In a video interview at the AAGL meeting, Dr. Vilos said the approach could be a “game changer” if it holds up in future testing.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

aotto@frontlinemedcom.com

Recommended Reading

Try testosterone only in women with hypoactive sexual desire
MDedge ObGyn
FDA warns against laparoscopic power morcellation
MDedge ObGyn
Multiple biopsies increase sensitivity of colposcopy
MDedge ObGyn
USPSTF: Not enough evidence for vitamin D screening
MDedge ObGyn
Sentinel lymph node mapping effective for staging early endometrial cancer
MDedge ObGyn
Careful screening catches sarcomas before morcellation
MDedge ObGyn
Medicare considers coverage of cervical cancer screening with HPV testing
MDedge ObGyn
Expert panel endorses continued use of morcellation
MDedge ObGyn
Abortion rates reach historic low in 2011
MDedge ObGyn
2014 Update on osteoporosis
MDedge ObGyn